The Organizing Committee is delighted to invite you to attend the 7th European Biosimilars Congress one of its remarkable Pharmaceutical conferences, to be held during May 15-17, 2017 in Munich, Germany. European Biosimilars Congress 2017 brings together scientists, researchers and CROs from around the world. With the approval of second biosimilar by the USFDA-Inflectra the biosimilars market is owned to experience a exponential growth over the coming few years. Many biologics products are making their entry in the pharma market and experiencing a notable rise in their usage over the conventional medications.
At Euro Biosimilars 2017 meet your target audiences from around the world focused on learning about biologics and biosimilars. This conference would be your single best opportunity to reach the largest assemblage of participants from the biologics and biosimilars community.